The antimicrobial treatment strategies (MIKSTRA) program: A 5-year follow-up of infection-specific antibiotic use in primary health care and the effect of implementation of treatment guidelines

Clinical Infectious Diseases

Volumn 42, Issue 9, 2006, Pages 1221-1230

  Rautakorpi, Ulla Maija ^a,h   Huikko, Solja ^a   Honkanen, Pekka ^f   Klaukka, Timo ^b   Mäkelä, Marjukka ^a   Palva, Erkki ^c   Roine, Risto ^d   Sarkkinen, Hannu ^g   Varonen, Helena ^e   Huovinen, Pentti ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c NATIONAL AGENCY FOR MEDICINES   (Finland)

^d HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

^e Finska Lo karforeningen Duodecim   (Finland)

^f Tornio Health Center   (Finland)

^g PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^h TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; NITROFURANTOIN; PENICILLIN V; PIVMECILLINAM; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL SKIN DISEASE; BRONCHITIS; CHILD; CLINICAL PRACTICE; FEMALE; FOLLOW UP; HEALTH CENTER; HEALTH PROGRAM; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; OTITIS MEDIA; PHARYNGITIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PUBLICATION; QUALITATIVE ANALYSIS; SINUSITIS; STATISTICAL SIGNIFICANCE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; FINLAND; GUIDELINE ADHERENCE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TIME FACTORS;

EID: 33646118245     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/503036     Document Type: Article

References (46)

1. Wise R, Hart T, Cars O, et al. Antimicrobial resistance. BMJ 1998; 317:609-10.
2. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A 1999; 96:1152-6.
3. Bergman M, Huikko S, Pihlajamaki M, et al. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 2004; 38:1251-6.
4. Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8:278-82.
5. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579-87.
6. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995; 21:1378-85.
7. Steinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin Infect Dis 2001;33(Suppl 3):S193-205.
8. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H. Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 2002; 155:472-7.
9. Maxwell PR, Rink E, Kumar D, Mendall MA. Antibiotics increase functional abdominal symptoms. Am J Gastroenterol 2002; 97:104-8.
10. Smith HS, Hughes JP, Hooton TM, et al. Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis 1997; 25:63-8.
11. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA 2004; 291:827-35.
12. Huovinen P, Cars O. Control of antimicrobial resistance: time for action. BMJ 1998; 317:613-4.
13. Belongia EA, Schwartz B. Strategies for promoting judicious use of antibiotics by doctors and patients. BMJ 1998; 317:668-71.
14. Ball P, Baquero F, Cars O, et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002; 49:31-40.
15. Rautakorpi UM, Lumio J, Huovinen P, Klaukka T. Indication-based use of antimicrobials in Finnish primary health care: description of a method for data collection and results of its application. Scand J Prim Health Care 1999; 17:93-9.
16. Rautakorpi UM, Klaukka T, Honkanen P, et al. Antibiotic use by indication: a basis for active antibiotic policy in the community. Scand J Infect Dis 2001; 33:920-6.
17. Käypä hoito-suositukset (in Finnish). Available at: http://www .duodecim.fi/kh. Accessed 27 March 2006.
18. MIKSTRA: Antimicrobial treatment strategy indication survey. Available at: http://www.stakes.fi/mikstra/e/questionnaires.html. Accessed 27 March 2006.
19. Blomgren K, Alho OP, Ertama L, et al. Acute sinusitis: Finnish clinical practice guidelines. Scand J Infect Dis 2005; 37:245-50.
20. Honkanen PO, Herva E, Kujala P, et al. Acute bronchitis: Finnish clinical practice guidelines (in Finnish). Duodecim 1999; 115:2171-5.
21. Ranki A, Hyry H, Jansson T, et al. Bacterial skin-infections: Finnish clinical practice guidelines (in Finnish). Duodecim 1999; 115:2139-46.
22. Puhakka HJ, Hagman E, Heikkinen T, et al. Acute otitis media: Finnish clinical practice guidelines (in Finnish). Duodecim 1999; 115:2155-61.
23. Sarkkinen H, Hirvonen T, Mäkelä M, Putto-Laurila A. Throat infection: Finnish clinical practice guidelines (in Finnish). Duodecim 1999; 115:2162-70.
24. Ikaheimo R, Uhari M, Lumio J, et al. Urinary tract infections: Finnish clinical practice guidelines (in Finnish). Duodecim 2000; 116:782-96.
25. MIKSTRA: Antimicrobial treatment strategy educational presentations. Available at: http://www.stakes.fi/mikstra/e/educational_presentations .html. Accessed 27 March 2006.
26. Rautakorpi U-M, Honkanen P, Huikko S et al. Nurses: too seldom used resource in management of patients with infections (in Finnish)? MIKSTRA Steering Group. Suom Lääkäril 2002; 44:4480-3.
27. Tuderman P, Klaukka T, Palva E. Antimicrobial treatment seems to have good compliance (in Finnish). MIKSTRA Steering Group. Suom Lääkä ril 2001;44:4510-1.
28. MIKSTRA Steering Group. More caution in the use of macrolides as first-line drugs: macrolide resistance of pneumococci is increasing (in Finnish). Suom Lääkäril 2000;43:4405-7.
29. MIKSTRA Steering Group. Antibiotics are prescribed more restrictively than before: first results of the MIKSTRA Program (in Finnish). Suom Lääkäril 1999; 29:3513-8.
30. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:iii-iv, 1-72.
31. Hux JE, Melady MP, DeBoer D. Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial. CMAJ 1999; 161:388-92.
32. Stewart J, Pilla I, Dunn L. Pilot study for appropriate anti-infective community therapy: effect of a guideline-based strategy to optimize use of antibiotics. Can Fam Physician 2000; 46:851-9.
33. Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJM. Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ 2004; 329:431-3.
34. Coenen S, Van Royen P, Michiels B, Denekens J. Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial. J Antimicrob Chemother 2004; 54:661-72.
35. Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA 2002; 287:3103-9.
36. Rubin MA, Bateman K, Alder S, Donnelly S, Stoddard GJ, Samore MH. A multifaceted intervention to improve antimicrobial prescribing for upper respiratory tract infections in a small rural community. Clin Infect Dis 2005; 40:545-53.
37. Zwar N, Henderson J, Britt H, McGeechan K, Yeo G. Influencing antibiotic prescribing by prescriber feedback and management guidelines: a 5-year follow-up. Fam Pract 2002; 19:12-7.
38. Munck AP, Gahrn-Hansen B, Søgaard P, Søgaard J. Long-lasting improvement in general practitioners' prescribing of antibiotics by means of medical audit. Scand J Prim Health Care 1999; 17:185-90.
39. Virtanen P, Vänskä J, Halila H. Physician labor in health centers in October 2004 (in Finnish). Suom Laakaril 2004; 59:4877-80.
40. Andre M, Odenholt I, Schwan A, et al. Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests. Scand J Infect Dis 2002; 34:880-6.
41. Stålsby Lundborg C, Olsson E, Molstad S, Swedish Study Group on Antibiotic Use. Antibiotic prescribing in outpatients: a 1-week diagnosis-prescribing study in 5 counties in Sweden. Scand J Infect Dis 2002; 34:442-8.
42. Wang EEL, Einarson TR, Kellner JD, Conly JM. Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis 1999; 29:155-60.
43. Glasziou PP, Del Mar CB, Sanders SL, Hayem M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2004; 1:CD000219.
44. Williams JW Jr, Aguilar C, Cornell J, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2003; 2:CD000243.
45. Fahey T, Smucny J, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2004; 4:CD000245.
46. Varonen H, Rautakorpi UM, Huikko S, et al. Management of acute maxillary sinusitis in Finnish primary care. Scand J Prim Health Care 2004; 22:122-7.